Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Herbert J. Conrad currently holds 16,500 shares of Celldex Therapeutics, Inc. (CLDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Herbert J. Conrad has been a net seller of CLDX stock. They have purchased $154.0K and sold $5.5M worth of shares.
Herbert J. Conrad's most recent insider trade was on Jun 13, 2024, when they sold 16,500 shares at $0.00 per share.
Herbert J. Conrad serves as Executive at Celldex Therapeutics, Inc. (CLDX). They have executed 104 insider transactions totaling $5.7M over their tenure at the company.
Herbert J. Conrad holds the position of Executive at Celldex Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Herbert J. Conrad has shown a selling trading pattern, with $154.0K in total purchases and $5.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Herbert J. Conrad was on May 3, 2011, when they sold $4.0M worth of VRUS shares. This transaction involved 40,000 shares at $99.04 per share.
Herbert J. Conrad currently owns 16,500 shares of Celldex Therapeutics, Inc. (CLDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Herbert J. Conrad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Herbert J. Conrad has 104 Form 4 filings on record as an insider at Celldex Therapeutics, Inc..
Set alerts for Herbert J. Conrad and 40,000+ other insiders.